H. Gamm

667 total citations
17 papers, 478 citations indexed

About

H. Gamm is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, H. Gamm has authored 17 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Hematology. Recurrent topics in H. Gamm's work include Bone health and treatments (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Pain Management and Opioid Use (2 papers). H. Gamm is often cited by papers focused on Bone health and treatments (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Pain Management and Opioid Use (2 papers). H. Gamm collaborates with scholars based in Germany and United States. H. Gamm's co-authors include Christian Walter, Wilfried Wagner, Bilal Al‐Nawas, Knut A. Grötz, Joachim Beck, A. Lindemann, F. Herrmann, Joachim W. Thüroff, Roland Mertelsmann and Christian Thomas and has published in prestigious journals such as Blood, European Urology and British Journal of Haematology.

In The Last Decade

H. Gamm

15 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Gamm Germany 9 250 155 90 81 76 17 478
Michael M. Schündeln Germany 11 160 0.6× 58 0.4× 80 0.9× 95 1.2× 64 0.8× 29 474
Rıdvan Mercan Türkiye 12 89 0.4× 64 0.4× 91 1.0× 122 1.5× 206 2.7× 52 521
Fara Petruzziello Italy 12 171 0.7× 37 0.2× 160 1.8× 99 1.2× 34 0.4× 25 444
Payam Entezami United States 9 136 0.5× 75 0.5× 16 0.2× 131 1.6× 52 0.7× 20 389
Y. Hirano Japan 14 61 0.2× 68 0.4× 106 1.2× 63 0.8× 326 4.3× 70 580
Yoshihisa Morishita Japan 12 132 0.5× 40 0.3× 210 2.3× 104 1.3× 14 0.2× 36 414
Stefan Bruijnen Netherlands 10 60 0.2× 57 0.4× 22 0.2× 37 0.5× 163 2.1× 15 359
Z N Jahangier Netherlands 12 48 0.2× 48 0.3× 61 0.7× 24 0.3× 232 3.1× 18 377
Julien Henry France 12 37 0.1× 69 0.4× 28 0.3× 25 0.3× 121 1.6× 30 451
Olga García Spain 11 37 0.1× 34 0.2× 58 0.6× 49 0.6× 57 0.8× 40 387

Countries citing papers authored by H. Gamm

Since Specialization
Citations

This map shows the geographic impact of H. Gamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Gamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Gamm more than expected).

Fields of papers citing papers by H. Gamm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Gamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Gamm. The network helps show where H. Gamm may publish in the future.

Co-authorship network of co-authors of H. Gamm

This figure shows the co-authorship network connecting the top 25 collaborators of H. Gamm. A scholar is included among the top collaborators of H. Gamm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Gamm. H. Gamm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Walter, Christian, Bilal Al‐Nawas, Norbert Frickhofen, et al.. (2010). Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients. Head & Face Medicine. 6(1). 11–11. 63 indexed citations
2.
Walter, Christian, Bilal Al‐Nawas, Knut A. Grötz, et al.. (2008). Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with Zoledronate. European Urology. 54(5). 1066–1072. 125 indexed citations
4.
Rummel, Mathias, Stephan Stilgenbauer, H. Gamm, et al.. (2005). Fludarabine Versus Fludarabine Plus Epirubicin in the Treatment of Chronic Lymphocytic Leukemia - Final Results of a German Randomized Phase-III Study.. Blood. 106(11). 2123–2123. 5 indexed citations
5.
Weber, M., Joachim Schüz, Jürgen Kuball, H. Gamm, & J. Jage. (2005). Schmerzerfassung bei invasiven diagnostischen Prozeduren. Der Schmerz. 19(6). 513–520. 5 indexed citations
6.
Kuball, Jürgen, Joachim Schüz, H. Gamm, & M. Weber. (2004). Bone marrow punctures and pain. Acute Pain. 6(1). 9–14. 41 indexed citations
7.
Kindler, Thomas, Frank Breitenbuecher, Andreas Marx, et al.. (2003). Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML. Blood. 101(8). 2960–2962. 39 indexed citations
8.
Düber, C, et al.. (2000). Das Chlorom (Granulozytäres Sarkom, Myeloblastom) - Klinik und radiologische Diagnostik -. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 172(3). 282–286. 5 indexed citations
9.
Heß, Georg, et al.. (1994). Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera. British Journal of Haematology. 88(4). 794–802. 51 indexed citations
10.
Bornemann, A., et al.. (1993). Amyloidoma of the gasserian ganglion as a cause of symptomatic neuralgia of the trigeminal nerve: Report of three cases. Journal of Neurology. 241(1). 10–14. 39 indexed citations
11.
Gamm, H., A. Lindemann, Roland Mertelsmann, & F. Herrmann. (1991). Phase I trial of recombinant human tumour necrosis factor α in patients with advanced malignancy. European Journal of Cancer and Clinical Oncology. 27(7). 856–863. 53 indexed citations
12.
Schraven, Burkhart, et al.. (1991). Natural inhibitors of T-cell activation in Hodgkin's disease. Blood. 78(9). 2365–2371. 8 indexed citations
13.
Schraven, Burkhart, et al.. (1991). Natural inhibitors of T-cell activation in Hodgkin's disease. Blood. 78(9). 2365–2371. 2 indexed citations
14.
Lindemann, A., K. H�ffken, R. E. Schmidt, et al.. (1989). A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma. Cancer Immunology Immunotherapy. 28(4). 275–81. 35 indexed citations
15.
Jung, Helene, et al.. (1975). Klinisch-experimentelle Studie zur szintigraphischen Darstellung maligner Kopf-Hals-Neoplasien mit57Cobalt-Bleomycin. European Archives of Oto-Rhino-Laryngology. 211(2). 129–138.
16.
Jung, Helene, et al.. (1974). [Tumorscanning of head and neck with 57Co-bleomycine (author's transl)].. PubMed. 14(11). 513–6. 1 indexed citations
17.
Fischer, J, et al.. (1971). [First experiences with bone-marrow scintigraphy in the hospital].. PubMed. 77. 409–12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026